RecruitingNot ApplicableNCT04039633

Spinal Cord Stimulation for Refractory Pain in Erythromelalgia


Sponsor

St. Olavs Hospital

Enrollment

24 participants

Start Date

Aug 26, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Erythromelalgia is a rare disorder characterized by red, warm, and painful extremities, which is often precipitated by warm conditions. The pathophysiology is incompletely understood. The management of pain in erythromelalgia is challenging as no single therapy has been found to be effective. Response to pharmacotherapy varies, meaning that the physician has to take a stepwise trial and error approach with each patient. Consequently, this disorder is often associated with poorer health-related quality of life. There is currently no consensus or guideline on management of pain in erythromelalgia. Spinal cord stimulation is a widely applied therapy to treat severe chronic pain of various origin. Case reports and anecdotal evidence suggest that this therapy might alleviate refractory pain in patients with erythromelalgia. The aim of this trial is to evaluate the efficacy of spinal cord stimulation for refractory pain in erythromelalgia.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Burst Spinal Cord Stimulation and a procedure called Sham spinal cord stimulation for people with erythromelalgia. The study is currently recruiting participants at 4 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBurst Spinal Cord Stimulation

Burst stimulation utilizes complex programming to deliver high-frequency stimuli of a 40 Hz burst mode with 5 spikes at 500 Hz per spike delivered in a constant current mode

PROCEDURESham spinal cord stimulation

A pulse generator is implanted, but no spinal cord stimulation is provided


Locations(4)

Halden Dermatology Center

Halden, Norway

Aleris

Strømmen, Norway

Universitetssykehuset nord-norge hf

Tromsø, Norway

St Olavs Hospital

Trondheim, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04039633